Separate names with a comma.
XXII Products: X-22: Smoking Cessation Aid In Development X-22 is a kit containing Very Low Nicotine (VLN) cigarettes that will go through the...
22nd Century Produces Non-GMO Very Low Nicotine Tobacco June 06, 2017 Non-GMO tobacco varieties will open new markets worldwide CLARENCE,...
22nd Century Group Receives Order for 2.4 Million SPECTRUM® U.S. Government Research Cigarettes June 01, 2017 CLARENCE, N.Y.--(BUSINESS WIRE)--...
22nd Century Raises 2017 Revenue Projection to $16Million – Another Record Year May 09, 2017 Factory will be profitable in 2018 CLARENCE,...
22nd Century is a plant biotechnology company with an important mission: To Reduce the Harm Caused by Smoking. Our proprietary genetic...
Amazon earnings: $1.78 per share, vs expected EPS of $1.11 http://www.cnbc.com/2016/07/28/amazon-reporting-second-quarter-earnings.html
I wonder how AWS growth will be compared to Azure. I was right last time I gambled earnings here with the miss in Q4, took a long this time...
Cellceutix Expedites Phase 2 Trial of Brilacidin-OM for Oral Muscositis BEVERLY, MA –(Marketwired – July 21, 2016) - Cellceutix Corporation,...
Cellceutix Recieves Update on First Patient Enrolled in Phase 2 Proof-of-Concept Study of Brilacidin for Ulcerative Proctitis Company Encouraged...
Cellceutix to Initiate Phase 2b Trial of Prurisol for Chronic Plaque Psoriasis BEVERLY, MA–(Marketwired – July 07, 2016) - Cellceutix...
Cellceutix Corporation Announces Industry Veteran Arthur P. Bertolino, MD, PhD, MBA Joins Company as President and Chief Medical Officer BEVERLY,...
Results were positive, no price action. Don't know what it will take to finally drag this out of the gutter. Trial results clearly aren't doing...
BEVERLY, MA–(Marketwired – May 24, 2016) - Cellceutix Corporation (OTC: CTIX) (the “Company”), a clinical stage biopharmaceutical company...
Results were reported to be unblinded last week, results probable for this week. This is a binary event that will either send the stock back to 1$...
[ATTACH] Looking strong going into probable Phase 2 Trial results release within the next couple week for Prurisol, the long forgotten (or just...
Wow @ SLV... was up huge pre-market to boot.
Strong couple of days, broke out of previous resistance levels. Frustrating cause I sold all of my USLV like a month ago...
Cellceutix Institutes "Database Soft-Lock" on it's Phase 2 Psoriasis Clinical Results, Top Line Results Expected in May; Additional Comany Updates...
A Booming Psoriasis Market With approximately 7.5 million psoriasis patients alone in the United States, and nearly 80-90 percent of those...
Can Cellceutix Emerge From The Shadows Into The Limelight? Apr. 19, 2016 4:34 PM ET | 14 comments | About: Cellceutix Corp. (CTIX), Includes:...
